Condition: Major Depressive Disorder · Sponsor: Mclean Hospital
This study looks at the role of the Nociceptin/Orphanin FQ receptor system in the brain of individuals with current or past major depressive disorder (MDD). It also examines how individuals with a history of depression make certain decisions and which brain regions are involved in such decisions. Information collected through MRI, PET, biospecimens (i.e., blood, saliva) and behavioral tasks will be used to predict depressive symptoms in the future.
This description comes directly from the study's public registry record.
Tracy Lam, BS · 617-855-4437 · mclrew41study@mgb.org
David Crowley, ALM · 617-855-4432 · djcrowley@mclean.harvard.edu
Always discuss trial participation with your own doctor first.
| McLean Hospital | Belmont, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05630963